Together, these hormones help to slow down gastric emptying, reduce appetite, improve insulin sensitivity, and lower blood glucose levels
The Therapeutic Goods Administration (TGA) has today (Monday 1 December) made updates to product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues
SIRT1 is a histone deacetylase that requires NAD + and is implicated in mitochondrial biogenesis (Li and Laher, 2014)
The most remarkable finding in the current study, is that all treatments (LC, LCLN, QT, and QTLN) significantly upregulated the expression of all studied steroidogenic genes, thereby significantly reducing the deleterious effects of ATZ on steroidogenesis
For more information, check out our blog post - BioPures Formulas From the Bottom Up